Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure
Alessandra Dei(University of Parma), Gregg C. Fonarow(UCLA Medical Center), Robert O. Bonow(Northwestern University), Angelo Avogaro(University of Padua), Michele Senni(Inserm), Robert J. Mentz(Duke University), Wolfram Doehner(Deutsches Herzzentrum der Charité), Javed Butler(Saint Luke's Health System), Sadiya S. Khan(Northwestern University), Stephen J. Greene(Duke Medical Center), Mihai Gheorghiade(Northwestern University), Diethelm Tschoepe(Heart and Diabetes Center North Rhine-Westphalia)
Cited by 409
Related Papers
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
|Circulation|2020|9.4k
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
|Circulation|2019|9.1k
Heart Disease and Stroke Statistics—2021 Update
|Circulation|2021|5.7k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k